Kodiak Sciences (KOD) EBT (2017 - 2026)
Kodiak Sciences' (KOD) quarterly EBT came in at -$522.5 million in Q1 2026, down 780.19% YoY from $76.8 million in Q1 2025, and down 35.73% on a QoQ basis from -$385.0 million in Q4 2025.
Kodiak Sciences (KOD) EBT (2017 - 2026) Analysis & Trends
Kodiak Sciences (KOD) has 10 years of EBT data on file, last reported at -$522.5 million in Q1 2026.
- Quarterly EBT fell 780.19% year-over-year to -$522.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.2 billion (down 512.96% YoY) and the FY2025 annual result came in at -$558.2 million, down 31.98% from the prior year.
- EBT eased to -$522.5 million in Q1 2026, from -$385.0 million in the prior quarter.
- In the past five years, EBT ranged from a high of -$44.8 million in Q1 2024 to a low of -$522.5 million in Q1 2026.
- A 5-year average of -$122.0 million and a median of -$74.5 million in 2023 frame the typical range for EBT.
- Annual changes were most pronounced in 2022 — EBT soared 84.3% — and 2026, when it sank 780.19%.
- Tracing KOD's EBT over 5 years: stood at -$71.1 million in 2022, then dropped by 5.02% to -$74.6 million in 2023, then surged by 39.76% to -$44.9 million in 2024, then sank by 756.48% to -$385.0 million in 2025, then tumbled by 35.73% to -$522.5 million in 2026.
- The last three EBT figures came in at -$522.5 million (Q1 2026), -$385.0 million (Q4 2025), and -$228.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Kodiak Sciences | 2.60 Bn | 2.60 Bn | - | -518.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -518.88 Mn |
| Mar 31, 2026 | -522.55 Mn |
| Dec 31, 2025 | -384.98 Mn |
| Sep 30, 2025 | -228.01 Mn |
| Jun 30, 2025 | -60.04 Mn |
| Mar 31, 2025 | -59.37 Mn |
| Dec 31, 2024 | -44.95 Mn |
| Sep 30, 2024 | -45.11 Mn |
| Jun 30, 2024 | -45.62 Mn |
| Mar 31, 2024 | -44.77 Mn |
| Dec 31, 2023 | -74.62 Mn |
| Sep 30, 2023 | -50.31 Mn |
| Jun 30, 2023 | -85.17 Mn |
| Mar 31, 2023 | -74.50 Mn |
| Dec 31, 2022 | -71.05 Mn |
| Sep 30, 2022 | -83.64 Mn |
| Jun 30, 2022 | -97.02 Mn |
| Mar 31, 2022 | -102.26 Mn |
| Dec 31, 2021 | -93.03 Mn |
| Sep 30, 2021 | -498.78 Mn |